Reata Pharmaceuticals holds a performance score of 8 on a scale of zero to a hundred. The company holds a Beta of 1.003, which implies a somewhat significant risk relative to the market. Let's try to break down what Reata's beta means in this case. Reata Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Reata Pharmaceuticals is expected to follow. Although it is essential to pay attention to Reata Pharmaceuticals current trending patterns, it is also good to be reasonable about what you can do with equity existing price patterns. Our philosophy towards forecasting future potential of any stock is to look not only at its past charts but also at the business as a whole, including all available fundamental and technical indicators. To evaluate if Reata Pharmaceuticals expected return of 3.05 will be sustainable into the future, we have found twenty-eight different technical indicators, which can help you to check if the expected returns are sustainable. Use Reata Pharmaceuticals information ratio, downside variance, day median price, as well as the relationship between the treynor ratio and kurtosis to analyze future returns on Reata Pharmaceuticals.